Medical Center of Central Georgia
777 Hemlock Street
Macon, Georgia 31201
(478) 633-1000 http://www.navicenthealth.org

Use our guide to learn which trials are right for you!

Navicent Health is a designated Level I Trauma Center and one of 42 twice-designated Magnet® hospitals for nursing excellence nationwide. It provides a broad range of community-based, outpatient diagnostic, primary care, extensive home health and hospice care, and comprehensive cancer and rehabilitation services.

As a part of Central Georgia Health System (CGHS), Navicent Health is a 501(c)(3) private, not for-profit corporation. The hospital is owned by the Macon-Bibb Hospital Authority and maintains an active affiliation with Secure Health Plans of Georgia, a network of central Georgia hospitals and physician providers.

Distinguished nationally for its excellence, Navicent Health is also one of the premier teaching hospitals in the United States and serves as the primary teaching hospital for the Mercer University School of Medicine. Navicent Health supports residency-training programs in family practice, general surgery, internal medicine, obstetrics and gynecology and pediatrics. The hospital has more than 100 medical residents and fellows in training. As a teaching hospital, Navicent Health is able to attract the best and the brightest to the area.

We've found
13 trials
at this facility
Venous Thrombo-embolism Clinical Trial
National Inferior Vena Cava (IVC) Filter Registry
Status: Enrolling
Updated: 12/3/2012
mi
from
Macon, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Macon, GA
Click here to add this to my saved trials